Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder (vol 159, pg 255, 2002)

被引：0
|
作者：
Volavka
机构：
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2002年 / 159卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：2132 / 2132
页数：1
相关论文
共 50 条
  • [41] Comments to the editor on "Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: A Markov model"
    Clewell, JD
    Baker, RW
    [J]. VALUE IN HEALTH, 2005, 8 (02) : 175 - 176
  • [42] REHOSPITALIZATION RATES OF PATIENTS DISCHARGED WITH HALOPERIDOL OR OLANZAPINE OR RISPERIDONE OR SULPIRIDE OR ZIPRASIDONE OR CLOZAPINE AND ITS RELATION TO PREVIOUS TREATMENT
    Werneck, Ana Paula
    Elkis, H.
    Pinto, J. A.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 65 - 65
  • [43] Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia
    Zoccali, R
    Muscatello, MR
    La Torre, D
    Malara, G
    Canale, A
    Crucitti, D
    D'Arrigo, C
    Spina, E
    [J]. PHARMACOLOGICAL RESEARCH, 2003, 48 (04) : 411 - 414
  • [44] Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
    McEvoy, JP
    Lieberman, JA
    Stroup, TS
    Davis, SM
    Meltzer, HY
    Rosenheck, RA
    Swartz, MS
    Perkins, DO
    Keefe, RSE
    Davis, CE
    Severe, J
    Hsiao, JK
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (04): : 600 - 610
  • [45] Risperidone versus haloperidol-sertraline in the acute phase of treatment of patients with schizoaffective disorder, depressive type
    Izakova, L.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S223 - S224
  • [46] An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: Comparisons with placebo, haloperidol, risperidone, or clozapine
    Carlson, CD
    Cavazzoni, PA
    Berg, PH
    Wei, H
    Beasley, CM
    Kane, JM
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (08) : 898 - 906
  • [47] Treatment-emergent tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Miller, D. D.
    Kim, E.
    Eudicone, J.
    Pikalov, A.
    Vester-Blokland, E.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 503 - 503
  • [48] Incidence and severity of tardive dyskinesia in patients receiving artpiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Sanchez, R.
    Kim, E.
    Eudicone, J.
    Pikalov, A.
    Vester-Blokland, E.
    Miller, D. D.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S138 - S138
  • [49] Incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Miller, Delwyn D.
    Kim, Edward
    Eudicone, James
    Pikalov, Andrei A.
    Vester-Blokland, Estelle
    Coryell, William H.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S123 - S123
  • [50] Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol
    Markianos, M
    Hatzimanolis, J
    Lykouras, L
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (03) : 141 - 146
12345